WOCKHARDT ON THE MARKET

Indian pharmaceutical giant Wockhardt is currently in merger talks. The company, known for its extensive portfolio of generic and branded drugs, has been facing headwinds in recent quarters. Sources close to the deal suggest that Wockhardt is {attracting interest from|receiving bids from both domestic and international companies. A final decision i